Literature DB >> 17614361

Characterization of a cyclosporine solid dispersion for inhalation.

Gerrit S Zijlstra1, Michiel Rijkeboer, Dirk Jan van Drooge, Marc Sutter, Wim Jiskoot, Marco van de Weert, Wouter L J Hinrichs, Henderik W Frijlink.   

Abstract

For lung transplant patients, a respirable, inulin-based solid dispersion containing cyclosporine A (CsA) has been developed. The solid dispersions were prepared by spray freeze-drying. The solid dispersion was characterized by water vapor uptake, specific surface area analysis, and particle size analysis. Furthermore, the mode of inclusion of CsA in the dispersion was investigated with Fourier transform infrared spectroscopy. Finally, the dissolution behavior was determined and the aerosol that was formed by the powder was characterized. The powder had large specific surface areas (~ 160 m(2)). The water vapor uptake was dependant linearly on the drug load. The type of solid dispersion was a combination of a solid solution and solid suspension. At a 10% drug load, 55% of the CsA in the powder was in the form of a solid solution and 45% as solid suspension. At 50% drug load, the powder contained 90% of CsA as solid suspension. The powder showed excellent dispersion characteristics as shown by the high emitted fraction (95%), respirable fraction (75%), and fine-particle fraction (50%). The solid dispersions consisted of relatively large (x(50) approximately 7 mum), but low-density particles (rho approximately 0.2 g/cm(3)). The solid dispersions dissolved faster than the physical mixture, and inulin dissolved faster than CsA. The spray freeze-drying with inulin increased the specific surface area and wettability of CsA. In conclusion, the developed powder seems suitable for inhalation in the local treatment of lung transplant patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17614361      PMCID: PMC2751408          DOI: 10.1208/aapsj0902021

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  39 in total

1.  Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures.

Authors:  A H de Boer; P Hagedoorn; D Gjaltema; J Goede; H W Frijlink
Journal:  Int J Pharm       Date:  2003-07-24       Impact factor: 5.875

2.  Mucociliary and long-term particle clearance in the airways of healthy nonsmoker subjects.

Authors:  Winfried Möller; Karl Häussinger; Renate Winkler-Heil; Willi Stahlhofen; Thomas Meyer; Werner Hofmann; Joachim Heyder
Journal:  J Appl Physiol (1985)       Date:  2004-09-03

Review 3.  Dry powder inhalers for pulmonary drug delivery.

Authors:  H W Frijlink; A H De Boer
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

4.  Comparison of cascade impaction and laser diffraction for particle size distribution measurements.

Authors:  Jochen Ziegler; Herbert Wachtel
Journal:  J Aerosol Med       Date:  2005

5.  Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states.

Authors:  B S Kendrick; A Dong; S D Allison; M C Manning; J F Carpenter
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

Review 6.  Recent advances in pulmonary drug delivery using large, porous inhaled particles.

Authors:  D A Edwards; A Ben-Jebria; R Langer
Journal:  J Appl Physiol (1985)       Date:  1998-08

7.  A randomized trial of inhaled cyclosporine in lung-transplant recipients.

Authors:  Aldo T Iacono; Bruce A Johnson; Wayne F Grgurich; J Georges Youssef; Timothy E Corcoran; Deidre A Seiler; James H Dauber; Gerald C Smaldone; Adriana Zeevi; Samuel A Yousem; John J Fung; Gilbert J Burckart; Kenneth R McCurry; Bartley P Griffith
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

8.  Fourier transform infrared spectrometric analysis of protein conformation: effect of sampling method and stress factors.

Authors:  M van de Weert; P I Haris; W E Hennink; D J Crommelin
Journal:  Anal Biochem       Date:  2001-10-15       Impact factor: 3.365

9.  Bioavailability of cyclosporin A dispersed in sodium lauryl sulfate-dextrin based solid microspheres.

Authors:  E J Lee; S W Lee; H G Choi; C K Kim
Journal:  Int J Pharm       Date:  2001-05-07       Impact factor: 5.875

10.  Secondary structure of cyclosporine in a spray-dried liquid crystal by FTIR.

Authors:  Cynthia L Stevenson; Mandy M Tan; David Lechuga-Ballesteros
Journal:  J Pharm Sci       Date:  2003-09       Impact factor: 3.534

View more
  8 in total

1.  Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study.

Authors:  Sonali R Naikwade; Amrita N Bajaj; Prashant Gurav; Madhumanjiri M Gatne; Pritam Singh Soni
Journal:  AAPS PharmSciTech       Date:  2009-08-01       Impact factor: 3.246

2.  Porous mannitol carrier for pulmonary delivery of cyclosporine A nanoparticles.

Authors:  Sharon Shui Yee Leung; Jennifer Wong; Heloisa Victorino Guerra; Kevin Samnick; Robert K Prud'homme; Hak-Kim Chan
Journal:  AAPS J       Date:  2017-01-09       Impact factor: 4.009

3.  Formulation and evaluation of a protein-loaded solid dispersions by non-destructive methods.

Authors:  Ziyaur Rahman; Ahmed S Zidan; Mansoor A Khan
Journal:  AAPS J       Date:  2010-02-03       Impact factor: 4.009

4.  Cyclosporin A inhibits CD11a/CD18 adhesion molecules due to inhibition of TNFalpha and IL-1 beta levels in the mouse model of pleurisy induced by carrageenan.

Authors:  Eduardo Monguilhott Dalmarco; Yara Santos Medeiros; Tânia Silvia Fröde
Journal:  Cell Adh Migr       Date:  2008-10-23       Impact factor: 3.405

5.  Biopharmaceutical Evaluation of Novel Cyclosporine A Nano-matrix Particles for Inhalation.

Authors:  Hideyuki Sato; Hiroki Suzuki; Keisuke Yakushiji; Jennifer Wong; Yoshiki Seto; Robert K Prud'homme; Hak-Kim Chan; Satomi Onoue
Journal:  Pharm Res       Date:  2016-05-25       Impact factor: 4.200

6.  In-situ freeze-drying - forming amorphous solids directly within capsules: An investigation of dissolution enhancement for a poorly soluble drug.

Authors:  Abdulmalik Alqurshi; K L Andrew Chan; Paul G Royall
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

7.  Design and Characterization of Atorvastatin Dry Powder Formulation as a potential Lung Cancer Treatment.

Authors:  Alaa S Tulbah; Amr Gamal
Journal:  Saudi Pharm J       Date:  2021-11-11       Impact factor: 4.330

8.  Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery.

Authors:  Xiao Wu; Weifen Zhang; Don Hayes; Heidi M Mansour
Journal:  Int J Nanomedicine       Date:  2013-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.